Glioblastoma is the most common form of brain cancer in adults, and its consequences are usually quick and fatal. After ...

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

Mucommune, a Morrisville-based biotechnology company with roots at the University of North Carolina at Chapel Hill, has been ...

Researchers in India have created an AI tool called OncoMark that studies the inner workings of cancer cells. Instead of only ...

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

Vaccine Was Safe and Well Tolerated at the Maximum Tolerated Dose Results Support Advancement of the Program into Phase 2 Development Combination of Keytruda® and the ...

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the “Company” or “Telo”) a leader in the development of diagnostic and prognostic tests ...

November's wave of FDA oncology approvals signals the industry's shift toward platform-based precision therapies ...

Data demonstrates the significant and sustained tumor regression achieved by the CAPTN-3 platform across two distinct tri-specific antibodies, IM1240 and IM1305, targeting different tumor antigens ...

A research team led by Erwin F. Wagner from the Medical University of Vienna has discovered a previously unknown molecular ...

A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...

An increasing number of people are suffering from gastrointestinal disorders (GIDs) due to unhealthy diet habits and the stress of the fast pace of modern life. Most of these people will be ...